Previous reports have highlighted increased BCAA levels in the plasma/sera and tissue samples of patients with breast cancer 47, and pancreatic cancer 48, whereas, downregulated protein expressions in BCAA pathway in intrahepatic cholangiocarcinoma 49. This evidence concerns the gene ARID4B and breast cancer.